Antioquia Gold Announces Private Placement Closing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Antioquia Gold Announces Private Placement Closing

CALGARY, ALBERTA--(Marketwired - May 8, 2013) - Antioquia Gold Inc. (the "Company") (TSX VENTURE:AGD)(OTCQX:AGDXF) is pleased to announce the first tranche closing of its previously-announced non-brokered private placement (the "Offering"), raising aggregate gross proceeds of $150,500 via the issuance of 4,300,000 common shares at a price of $0.035 per common share. The Company is pleased to report that it has received great interest for the Offering and expects that the remainder of the Offering amount (being $349,500) will be subscribed for in the next week. All of the proceeds from the first tranche closing will be used by the Company to pay a portion of its current outstanding payables.

The Offering is subject to receipt of all necessary regulatory approvals.

About Antioquia Gold Inc.

Antioquia Gold has been exploring for precious metals in Colombia since 2007 where its current holdings are close to 40,000 hectares located throughout Colombia. Antioquia's principal asset, which is being actively explored, is its 5,630 hectare Cisneros Project, located 55 km northeast of Medellin in the Department of Antioquia, Colombia. At the Cisneros Project the Company has conducted extensive geochemical and geophysical programs over the entire property and has identified to date eleven (11) exploration zones. On the original discovery zone it has drilled over 45,000 metres and is well versed in the understanding of the deposit type and the project's path to resource definition and production.

On behalf of Antioquia Gold Inc.

Fernando Jaramillo, President & CEO

READER ADVISORY

Statements in this press release may contain forward-looking information including statements regarding subscriptions for the Offering and expected timing of any future closings. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. Factors that could cause the actual results to differ materially from those in forward-looking statements include the continued availability of capital and financing and general economic, market or business conditions in North America and in South America. The reader is cautioned not to place undue reliance on any forward-looking information. There can be no assurance that the proposed private placement will be completed, that exploration programs in Indonesia or other project acquisitions will be completed or, if completed, will be successful.

The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as required by securities law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Antioquia Gold Inc. www.antioquiagoldinc.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 17

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 15

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 19

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 16

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 13

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 9

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 11

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 17

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Guaranty Bancshares Sale Investigation by Top Legal Team

Updated Category News Views 145

Understanding the Sale of Guaranty Bancshares, Inc. The recent announcement regarding the proposed sale of Guaranty Bancshares, Inc. to Glacier Bancorp, Inc. has garnered significant attention. Shareholders will reportedly receive 1.0000 share of Glacier stock for each share they hold in Guaranty. This transaction raises important questions regarding its valuation and the...

Continue Reading
Ascenz Marorka Enhances Fleet Performance Monitoring in the Americas

Updated Category News Views 147

Ascenz Marorka Enhances Fleet Performance Monitoring in the Americas Ascenz Marorka, the smart shipping arm of GTT, has recently made strides by expanding its Real-Time Fleet Performance Monitoring Service to encompass the Americas. This strategic development follows the success of deployments in renowned maritime hubs, showcasing Ascenz Marorka's commitment to enhancing...

Continue Reading
Ares Management Expands Renewable Energy Footprint with New Acquisition

Updated Category News Views 334

Ares Management Expands Renewable Energy Footprint Recently, Ares Management Corporation (NYSE: ARES) announced a remarkable acquisition that underscores their commitment to renewable energy. A fund managed under the Ares Infrastructure Opportunities strategy has secured a 49% stake in a diverse energy asset portfolio valued at approximately $2.9 billion. This strategic...

Continue Reading
RLX Technology Set to Share Financial Insights This Quarter

Updated Category News Views 145

RLX Technology to Announce Third Quarter Financial Results Internationally recognized for its innovative approach, RLX Technology Inc. (NYSE: RLX) is gearing up to unveil its financial performance for the third quarter, which will end September 30, 2025. This announcement will occur just before the U.S. markets open on November 14, 2025. As a global leader in the e-vapor...

Continue Reading
Grok AI Gets Federal Approval: Key Insights for Musk and Trump

Updated Category News Views 302

Grok AI Federal Approval Marks a New Era The approval for Elon Musk's AI chatbot, Grok, to be utilized by all federal agencies represents a groundbreaking development in how artificial intelligence can enhance government operations. The General Services Administration (GSA) has granted this approval along with special provisions from Musk's AI company, xAI. Understanding...

Continue Reading